Stocks Overview

LAST PRICE
16.3300
TODAY'S CHANGE (%)
Trending Up0.0700 (0.4305%)

Bid / Lots
15.3000/ 1
Ask / Lots
16.9000/ 1
Open / Previous Close
16.2900 / 16.2600
Day Range
Low 16.0750
High 16.7250
52 Week Range
Low 14.5500
High 32.5900
Volume
876,576
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Tuesday's close: 16.26
Time	Volume	ACAD
09:32 ET	2800	16.3
09:34 ET	15280	16.15
09:36 ET	100	16.19
09:38 ET	100	16.19
09:39 ET	400	16.17
09:41 ET	1900	16.1999
09:43 ET	750	16.13
09:45 ET	3800	16.08
09:48 ET	200	16.08
09:50 ET	805	16.11
09:52 ET	2155	16.19
09:54 ET	1521	16.26
09:56 ET	822	16.255
09:57 ET	300	16.25
09:59 ET	1400	16.255
10:01 ET	2100	16.21
10:03 ET	1203	16.19
10:06 ET	2576	16.195
10:08 ET	1176	16.18
10:10 ET	1100	16.19
10:12 ET	500	16.2
10:14 ET	1100	16.2
10:15 ET	1243	16.15
10:17 ET	1338	16.19
10:19 ET	1800	16.17
10:21 ET	600	16.21
10:24 ET	1600	16.235
10:26 ET	1137	16.28
10:28 ET	1781	16.29
10:30 ET	3422	16.34
10:32 ET	3225	16.34
10:33 ET	1874	16.33
10:35 ET	300	16.335
10:37 ET	1643	16.35
10:39 ET	3000	16.37
10:42 ET	5490	16.37
10:44 ET	300	16.375
10:46 ET	1034	16.38
10:48 ET	1283	16.4111
10:50 ET	1732	16.41
10:51 ET	943	16.42
10:53 ET	2417	16.44
10:55 ET	800	16.435
10:57 ET	5089	16.45
11:00 ET	3400	16.44
11:02 ET	2966	16.42
11:04 ET	881	16.405
11:06 ET	2405	16.4
11:08 ET	1706	16.405
11:09 ET	600	16.4
11:11 ET	1324	16.39
11:13 ET	100	16.385
11:15 ET	1400	16.4
11:18 ET	2222	16.37
11:20 ET	400	16.37
11:22 ET	2401	16.3806
11:24 ET	3098	16.38
11:26 ET	886	16.36
11:27 ET	700	16.36
11:29 ET	1500	16.395
11:31 ET	700	16.38
11:33 ET	300	16.37
11:36 ET	1621	16.35
11:38 ET	1300	16.38
11:40 ET	300	16.38
11:42 ET	1900	16.36
11:44 ET	1389	16.34
11:45 ET	200	16.355
11:47 ET	1100	16.35
11:49 ET	400	16.355
11:51 ET	1599	16.34
11:54 ET	500	16.35
11:56 ET	2372	16.37
11:58 ET	100	16.375
12:00 ET	1100	16.365
12:02 ET	400	16.36
12:03 ET	600	16.36
12:05 ET	2455	16.34
12:07 ET	600	16.355
12:09 ET	3908	16.385
12:12 ET	500	16.39
12:14 ET	2148	16.38
12:16 ET	200	16.39
12:18 ET	1591	16.38
12:20 ET	1100	16.37
12:21 ET	300	16.375
12:23 ET	600	16.38
12:25 ET	1997	16.39
12:27 ET	800	16.4
12:30 ET	500	16.405
12:32 ET	500	16.405
12:34 ET	1220	16.4
12:36 ET	500	16.41
12:38 ET	2631	16.405
12:39 ET	200	16.41
12:41 ET	1937	16.39
12:43 ET	1176	16.37
12:45 ET	500	16.365
12:50 ET	1572	16.36
12:52 ET	393	16.355
12:54 ET	800	16.345
12:56 ET	1043	16.35
12:57 ET	1042	16.36
12:59 ET	1600	16.355
01:01 ET	1135	16.361
01:03 ET	1232	16.36
01:06 ET	1200	16.36
01:08 ET	830	16.36
01:12 ET	400	16.365
01:14 ET	1614	16.36
01:15 ET	451	16.36
01:17 ET	100	16.36
01:19 ET	300	16.37
01:21 ET	500	16.375
01:24 ET	100	16.38
01:26 ET	2036	16.375
01:28 ET	700	16.385
01:30 ET	1400	16.39
01:32 ET	500	16.39
01:33 ET	1925	16.4
01:35 ET	300	16.4
01:37 ET	590	16.4
01:39 ET	1000	16.385
01:42 ET	950	16.42
01:44 ET	1281	16.42
01:46 ET	1100	16.425
01:48 ET	2000	16.415
01:50 ET	800	16.41
01:51 ET	1305	16.395
01:53 ET	1500	16.405
01:55 ET	1875	16.4
01:57 ET	200	16.395
02:00 ET	3811	16.4
02:02 ET	20908	16.6
02:04 ET	8506	16.66
02:06 ET	1900	16.61
02:08 ET	3501	16.59
02:09 ET	1200	16.49
02:11 ET	700	16.495
02:13 ET	7050	16.38
02:15 ET	4255	16.42
02:18 ET	12469	16.48
02:20 ET	2790	16.53
02:22 ET	3120	16.55
02:24 ET	800	16.53
02:26 ET	1586	16.55
02:27 ET	1032	16.57
02:29 ET	19344	16.63
02:31 ET	7068	16.65
02:33 ET	2276	16.65
02:36 ET	12162	16.66
02:38 ET	6452	16.62
02:40 ET	6608	16.725
02:42 ET	1599	16.69
02:44 ET	4365	16.6
02:45 ET	7421	16.45
02:47 ET	11909	16.58
02:49 ET	5605	16.57
02:51 ET	2607	16.57
02:54 ET	1997	16.67
02:56 ET	600	16.65
02:58 ET	1678	16.669
03:00 ET	2100	16.55
03:02 ET	5825	16.54
03:03 ET	7648	16.54
03:05 ET	3700	16.52
03:07 ET	4287	16.42
03:09 ET	1398	16.42
03:12 ET	2231	16.475
03:14 ET	7449	16.525
03:16 ET	1100	16.54
03:18 ET	1481	16.51
03:20 ET	4695	16.5
03:21 ET	3095	16.44
03:23 ET	3700	16.4
03:25 ET	1100	16.41
03:27 ET	3200	16.441
03:30 ET	2900	16.49
03:32 ET	2627	16.47
03:34 ET	2914	16.45
03:36 ET	1950	16.41
03:38 ET	3349	16.39
03:39 ET	2271	16.415
03:41 ET	3000	16.4
03:43 ET	1400	16.41
03:45 ET	5947	16.37
03:48 ET	2889	16.35
03:50 ET	2811	16.33
03:52 ET	3246	16.355
03:54 ET	3188	16.38
03:56 ET	7941	16.37
03:57 ET	5644	16.355
03:59 ET	157788	16.33

Data delayed at least 15 minutes.

Aug 28, 2024
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences, from 4:05PM ET on Wednesday Aug 28, 2024 by Dow Jones
  4:05PM ET on Wednesday Aug 28, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesACAD ACADIA Pharmaceuticals Inc	2.7B	90.1x	---
United StatesAZTA Azenta Inc	2.4B	-17.5x	---
United StatesPTCT PTC Therapeutics Inc	2.7B	-5.6x	---
United StatesGH Guardant Health Inc	3.1B	-6.1x	---
United StatesNVAX Novavax Inc	2.1B	-4.5x	---
United StatesCPRX Catalyst Pharmaceuticals Inc	2.4B	38.3x	---
As of 2024-09-19

Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.

Contact Information

Headquarters: 12830 El Camino Real, Suite 400SAN DIEGO, CA, United States 92130
Phone: 858-558-2871
Fax: 858-558-2872

Executives

Independent Chairman of the Board: Stephen Biggar
Chief Executive Officer, Director: Stephen Davis
Chief Financial Officer, Executive Vice President: Mark Schneyer
Chief Operating Officer, Executive Vice President, Head of Commercial: Brendan Teehan
Executive Vice President, Company Secretary and Chief Legal Officer: Jennifer Rhodes

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$2.7B
Revenue (TTM)	$890.5M
Shares Outstanding	165.9M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.39
EPS	$0.18
Book Value	$2.62
P/E Ratio	90.1x
Price/Sales (TTM)	3.0
Price/Cash Flow (TTM)	64.2x
Operating Margin	2.56%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

ACADIA Pharmaceuticals Inc
NASDAQ:ACADUnited States

Search Criteria

Charts

Recent News

Aug 28, 2024

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences, from 4:05PM ET on Wednesday Aug 28, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar